Bottom line
What does PHSTX hold?
PHSTX held 115 positions as of May 31, 2026. Its largest holding is Eli Lilly & Co. at 13.15% of the fund, and the top 10 positions add up to 61.1%. By asset type it is 98% stocks, 1% cash & short-term funds, 1% other.
Updated Jul 27, 2026
PHSTX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co. | Stocks | 13.15% | $192.5M |
| 2 | Johnson & Johnson | Stocks | 8.46% | $124.0M |
| 3 | UnitedHealth Group, Inc. | Stocks | 6.93% | $101.5M |
| 4 | AbbVie, Inc. | Stocks | 6.05% | $88.6M |
| 5 | Novartis AG | Stocks | 5.13% | $75.2M |
| 6 | Merck & Co., Inc. | Stocks | 4.88% | $71.5M |
| 7 | AstraZeneca plc | Stocks | 4.67% | $68.4M |
| 8 | Thermo Fisher Scientific, Inc. | Stocks | 4.50% | $65.9M |
| 9 | Intuitive Surgical, Inc. | Stocks | 4.04% | $59.2M |
| 10 | Sanofi SA | Stocks | 3.23% | $47.4M |
| 11 | Edwards Lifesciences Corp. | Stocks | 2.80% | $41.1M |
| 12 | Roche Holding AG | Stocks | 2.79% | $40.9M |
| 13 | CVS Health Corp. | Stocks | 2.74% | $40.1M |
| 14 | Gilead Sciences, Inc. | Stocks | 2.63% | $38.4M |
| 15 | McKesson Corp. | Stocks | 2.14% | $31.4M |
| 16 | Cardinal Health, Inc. | Stocks | 2.12% | $31.0M |
| 17 | Vertex Pharmaceuticals, Inc. | Stocks | 1.97% | $28.8M |
| 18 | Novo Nordisk A/S Novo Nordisk A/S, Class B |
Stocks | 1.90% | $27.9M |
| 19 | Boston Scientific Corp. | Stocks | 1.80% | $26.4M |
| 20 | Bristol-Myers Squibb Co. | Stocks | 1.75% | $25.6M |
| 21 | Dexcom, Inc. | Stocks | 1.64% | $24.0M |
| 22 | Hoya Corp. | Stocks | 1.52% | $22.2M |
| 23 | Putnam Short Term Investment Fund Putnam Short Term Investment Fund, Class P |
Other | 1.35% | $19.8M |
| 24 | HCA Healthcare, Inc. | Stocks | 1.18% | $17.3M |
| 25 | Amgen, Inc. | Stocks | 1.11% | $16.2M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 27, 2026